CEL-SCI Corporation (CVM) |
|
6.84 0.84 (14%)
|
07-15 16:00 |
|
Open: |
6.18 |
Pre. Close: |
6 |
|
High:
|
6.98 |
Low:
|
6 |
|
Volume:
|
1,005,169 |
Market Cap:
|
231M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
6.986 - 7.033 |
7.033 - 7.074 |
|
Low:
|
5.899 - 5.951 |
5.951 - 5.998 |
|
Close:
|
6.72 - 6.812 |
6.812 - 6.895 |
|
Technical analysis |
as of: 2019-07-15 4:41:17 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 8.61 One year: 10.50 |
| Support: |
Support1: 4.75 Support2: 3.95 |
| Resistance: |
Resistance1: 7.37 Resistance2: 8.99 |
| Pivot: |
7.93  |
| Moving Average: |
MA(5): 7.35 MA(20): 7.68
MA(100): 5.39 MA(250): 3.79 |
| MACD: |
MACD(12,26): 0.33 Signal(9): 0.58 |
| Stochastic oscillator: |
%K(14,3): 24.70 %D(3): 40.23 |
| RSI: |
RSI(14): 47.45 |
| 52-week: |
High: 8.99 Low: 0.82 Change(%): 632.3 |
| Average Vol(K): |
3-Month: 98878 10-Days: 78427 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.CVM has closed above bottom band by 13.6%. Bollinger Bands are 24.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Sun, 23 Jun 2019 14:07:33 Z
These 3 Biotech Stocks Skyrocketed Last Week -- Are They Buys Now?
Tue, 11 Sep 2018 16:47:57 Z
3 Small Biotech Stocks That Almost Doubled in Past Month
Fri, 07 Sep 2018 14:11:51 Z
Has Cel-Sci (CVM) Outpaced Other Medical Stocks This Year?
Fri, 31 Aug 2018 02:54:25 Z
Thursday Sector Leaders: Medical Instruments & Supplies, Biotechnology Stocks
Wed, 27 Jun 2018 20:08:02 Z
Wednesday Sector Laggards: Biotechnology, Drugs
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
29.77 |
| Shares Float (M) |
31.55 |
|
% Held by Insiders
|
5.41 |
|
% Held by Institutions
|
8.67 |
|
Shares Short (K)
|
3340 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-1.080 |
|
EPS Est. Current Year
|
-0.420 |
|
EPS Est. Next Year
|
-0.290 |
|
EPS Est. Next Quarter
|
|
|
Forward EPS
|
1.#IO |
|
Book Value (p.s.)
|
0.030 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-3122.67 |
|
Return on Assets (ttm)
|
-44.3 |
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
31.9 |
|
Gross Profit (p.s.)
|
-0.300 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-0.548 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-14.81 |
|
Levered Free Cash Flow (M)
|
-12.51 |
Stock Valuations |
|
P/E
|
-6.31 |
|
P/E Growth Ratio
|
0.14 |
|
P/BV
|
227.00 |
|
P/S
|
10136684544.00 |
|
P/CF
|
-13.69 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
1996-08-28 |
|
Forward Dividend
|
|
|
Last Split Date
|
2017-06-15 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
